Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CalciMedica Inc CALC

Healthcare
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

Recent & Breaking News (NDAQ:CALC)

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

PR Newswire 13 hours ago

CalciMedica Announces Presentations at Upcoming Medical Meetings

PR Newswire 1 day ago

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

PR Newswire 8 days ago

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

PR Newswire November 7, 2024

CalciMedica Announces Pricing of Public Offering of Common Stock

PR Newswire October 30, 2024

CalciMedica Announces Proposed Public Offering of Common Stock

PR Newswire October 30, 2024

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

PR Newswire October 30, 2024

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)

PR Newswire October 28, 2024

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

PR Newswire October 16, 2024

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire September 3, 2024

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

PR Newswire August 12, 2024

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora(TM) in Severe Acute Kidney Injury (AKI)

PR Newswire July 9, 2024

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

PR Newswire July 8, 2024

CalciMedica Set to Join Russell Microcap® Index

PR Newswire July 1, 2024

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)

PR Newswire June 27, 2024

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)

PR Newswire June 26, 2024

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

PR Newswire May 13, 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

PR Newswire May 7, 2024

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis

PR Newswire April 24, 2024

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

PR Newswire March 28, 2024